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Background
Autoimmune Deficiency Syndrome (AIDS) is a major pandemic, caused by the human immu-
nodeficiency virus (HIV). HIV targets CD4+ T lymphocytes and hinders the regulation and 
amplification of immune cells (Douek et al. 2002). This infection results in the persistent acti-
vation of immune system, and consequently, CD4+ T lymphocytes would greatly reduce in 
number resulting in body’s ability to fight against HIV infection. There is a need to understand 
the mechanism of immune activation and how it gets repressed by viral overload so the major 
elements of immune system that plays an important role are discussed below in detail.
Abstract 
Purpose: The complex interactions between genetic machinery of HIV-1 and host 
immune cells mediate dynamic adaptive responses leading to Autoimmune Deficiency 
Syndrome. These interactions are captured as Biological Regulatory Network (BRN) which 
acts to maintain the viability of host cell machinery through feedback control mechanism 
which is a characteristic of complex adaptive systems. In this study, the BRN of immune 
response against HIV-1 infection is modeled to investigate the role of NF-κB and TNF-α in 
disease transmission using qualitative (discrete) and hybrid modeling formalisms.
Methods: Qualitative and Hybrid modeling approaches are used to model the BRN for 
the dynamic analysis. The qualitative model is based on the logical parameters while 
the hybrid model is based on the time delay parameters.
Results: The qualitative model gives useful insights about the physiological condition 
observed as the homeostasis of all the entities of the BRN as well as pathophysiological 
behaviors representing high expression levels of NF-κB, TNF-α and HIV. Since the quali-
tative model is time abstracted, so a hybrid model is developed to analyze the behavior 
of the BRN by associating activation and inhibition time delays with each entity. HyTech 
tool synthesizes time delay constraints for the existence of homeostasis.
Conclusion: Hybrid model reveals various viability constraints that characterize the 
conditional existence of cyclic states (homeostasis). The resultant relations suggest 
larger cycle period of HIV-1 than the cycle periods of the other two entities (NF-κB and 
TNF-α) to maintain a homeostatic expressions of these entities.
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Tumor necrosis factor (TNF), also known as cachectin, is a cytokine primarily pro-
duced in activated immune system, and causes inflammation in acute infections (Legler 
et al. 2003). It is produced by activated macrophages, lymphocytes and monocytes elicits 
transcription as well as production of the inhibitor of kappa B (IκB) kinase enzyme after 
linking to corresponding receptors that results in the production of transcription fac-
tor NF-κB (Vitale and Ribeiro 2007). NF-κB, after activation, induces cytokines (mainly 
TNF-α and IL-1β) and causes inflammation (Bingham 3rd 2002) to hinder the entry of 
viral proteins into the cellular environment and initiates different immunological pro-
cesses (Bingham 3rd 2002). Studies indicate that TNF-α specifically attacks HIV-infected 








































































































































Fig. 1 HIV signaling and activation of Immune system in Macrophages (M). HIV proteins modify the signal-
ing pathways in both infected and uninfected cells by activating the transcription factors like NF-κB and AP-1. 
NF-κB has binding sites for both HIV LTR (long terminal repeat) as well as for TNF-α promoter (Adapted from 
Herbein et al. 2010)
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in Fig. 1. Few in-vitro studies prove that TNF-α stimulates the production of HIV mRNA 
indicating that TNF-α may be dose and time dependent on viral replication (Vitale 
and Ribeiro 2007). Macrophages serve as a reservoir for the virus and help the virus to 
propagate Swami (2013) as the HIV-1 virus releases its soluble exogenous proteins (NEF, 
TAT, VPR, GP120) to enter the macrophages, leading to transformation of both cellu-
lar and viral transcriptional machinery. Viral glycoprotein 120 (GP120) is essential for 
HIV-1 viral entry by interacting with surface receptors CD4 (Cluster of differentiation 4) 
and CXCR4 (CXC chemokine receptor 4) or CCR5 co-receptor (chemokine receptor 5) 
(Fig. 1) (Herbein et al. 1994, 2010; Melikyan 2008).
Another important protein that plays significant role both in innate and adaptive 
immune response is the transcription factor NF-κB. In the absence of foreign antigen(s) 
NF-κB dimers are retained in the cytoplasm through the inhibitory action of the IκB 
molecules (Ghosh and Karin 2002). The pro-inflammatory cytokines TNF-α and Inter-
leukin-1β (IL-1β) induce the activation of NF-κB pathway accompanied by rapid degra-
dation of IκB-α, releasing NF-κB dimers to the nucleus (Grey 2008), where they activate 
HIV transcription in infected cells (Ghosh and Karin 2002).
The immune regulators, such as cytokines, interact with the viral proteins in a feed-
back mechanism (see Fig. 1) to maintain homeostatic behavior of the organism. Homeo-
stasis is one of the vital creeds of self-regulation and internal organization and is defined 
as the synchronized physiological reactions responsible for maintaining most of the 
healthy states and conditions in the body. Positive and negative feedback loops induce 
an on/off switching mechanism (Brandman and Meyer 2008), which stops the respec-
tive activation state after the arrival of a set point or threshold (Thomas and Thieffry 
1995; Thomas et  al. 1998). Such feedback mechanisms represent a characteristic fea-
ture of complex adaptive systems which facilitates the emergence of complex patterns 
of behaviors such as homeostasis and stable states (reference: Complex Adaptive Sys-
tems Modeling: A multidisciplinary Roadmap). These positive and negative interactions 
among biological entities comprise a Biological Regulatory Network (BRN) provid-
ing the basis to converge into one of the many possible outcomes. The modeling and 
analysis of expression dynamics of BRNs can be used to increase our understanding of 
the underlying adaptive mechanisms in response to various stimuli but the presence 
of large number of unknown biological parameters e.g., kinetic rates of reactions and 
the expression values of molecules etc. makes it challenging. The kinetic logic mode-
ling formalism of Rene Thomas is one of the established methods to perform qualitative 
analysis of such systems (Thomas and Thieffry 1995; Gagneur and Casari 2005; De Jong 
et al. 2004) without any prior knowledge of kinetic parameters. The parameters of the 
model are computed using model checking technique based on the biological observa-
tions (see “Methods”). These parameters are then used to construct a qualitative model 
(state graph) which captures all the possible behaviors of the BRN as cyclic trajectories 
or paths diverging to the stable states. Rene Thomas has proved the similarity of differ-
ential equation models and qualitative models based on kinetic logic formalism in ([55] 
of rehan sepsis). However, qualitative modeling is more appropriate modeling paradigm 
due to its ability to infer unknown parameters ([56] of rehan sepsis). This formalism has 
been successfully implemented to gain insights into the pathogenesis clearance of Den-
gue virus and identification of the putative drug targets in Cerebral Malaria and Sepsis.
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Several signaling pathways have been carefully reviewed to construct a BRN based on HIV 
intervention of immune system (Fig. 1). In the current study, the qualitative model developed 
by Bibi et al. (2011) is employed to investigate the mode of immune activation in hindering 
HIV-1 viral proteins rapid expression. This approach facilitates in obtaining useful constraints 
that provides necessary conditions for the BRN to evolve and helps to analyze immune 
response of the body against foreign invaders. The HyTech model checker tool is used to ana-
lyze the hybrid model of the BRN (Ahmad et al. 2007) that generates delay constraints (Fro-
mentin et al. 2010) for the existence of a particular cyclic behavior (representing homeostasis). 
The model findings are in line with experimental data and provides novel insights into the 
disease propagation mechanism which could be used for its intervention strategies.
Methods
Discrete modeling formalism
The discrete modeling formalism of René Thomas (Ahmad et  al. 2012, 2007, 2009; 
Ahmad and Roux 2008; Thieffry and Thomas 1998; Thomas and D’Ari 1990), a type of 
qualitative logical modeling, has been successfully used for the construction of BRN 
models. This formalism uses a set of parameters that reflect the behaviors of a BRN in 
terms of the presence or absence of the regulatory elements (resources). Following are 
the formal definitions which are used to construct a discrete model of a BRN (Ahmad 
et al. 2012).
In a directed graph G = (X ,A), where X is a set of vertices (nodes) and A is a set of 
edges linking the vertices, G−(v) and G+(v) represent the set of predeccessors and suc-
cessors of a vertex v ∈ X respectively.
Definition 1 (Biological Regulatory Network) A BRN is a graph G = (X ,A) where X 
represents the set of nodes representing biological entities and A is the set of edges rep-
resenting interactions between biological entities. Each edge a→ b is labeled as (sab, 
rab ), where sab is a positive integer representing a threshold and rab ∈ {+,−} shows the 
type of interactions (‘+’ for activation and ‘−’ for inhibition).
A graphical representation for the activation and inhibition of v ∈ X is given in Fig. 2, 
where the rate of activation or inhibition depends upon a certain threshold level (θ). Pro-
duction of v increases rapidly once its activator u ∈ X reaches its threshold (θ). Likewise, 
the degradation of v occurs at maximum rate once its inhibitor w ∈ X reaches its thresh-
old level (θ). The threshold θ discretizes the expression of an activator (u) or inhibitor (w) 
into discrete (qualitative) levels represented by positive integers.
To analyze the behavior of a BRN, it is necessary to know all the possible states and the 
transitions between them. There is a limit discrete expression value lmv for each entity v 
of a BRN which is equal to its outgoing degree, such that ∀ u ∈ G+(v) each suv ∈ {1, . . . , nv 
} where nv ≤ lmv. Each entity carries its expression levels in the set Qv = {0, . . . , nv}.
Definition 2 (State) A state is a configuration of the expression levels of all entities at 
any instance of time and it is denoted by a tuple s ∈ §, where: 
§ = v∈XQv .
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A vector is normally used to show a qualitative state (lv)v∈X, where lv represents the 
expression level of the entity v.
A set of resources represents the activators of an entity at any instant of time.
Definition 3 (Resources) The set of resources R for a variable v ∈ X at some level lv is 
given as follows.
From the above definition, it can be inferred that the absence of an inhibitor below 
threshold is considered as a resource.
The set of logical parameters assigned to each biological entity determine the dynam-
ics of a BRN.
Definition 4 (Set of Logical Parameters) The set of logical parameters K(G) of a BRN is 
given below.
Kv,Rlv define the target expression level towards which the expression of entity v 
evolves.
Let l and K ∈ Z ≥ 0, the asynchronous evolution operator  (Bernot et  al. 2004) is 
given as:
Depending on the values of the logical parameters, the dynamics of a BRN is defined as 
a state graph.
Rlv = {u ∈ G
−
(v)|(lu ≥ suv and ruv = ‘ + ’) or (lu < suvand ruv = ‘ − ’)}.
K (G) = {Kv,Rlv ∈ {0, ...nv} | lv ∈ Qv ∀ v ∈ X}.
(1)l  K =


l + 1 if l < K
l − 1 if l > K
l if l = K
0  θ     1 u
Activation u           vθ, + Inhibition w          vθ, -
v fo etar noitcudorP
v fo etar noitadarge
D
0 θ        1 w
Fig. 2 Activation and inhibition of an entity v are represented by sigmoid curves. Step function represents its 
discrete approximation. The values 0 and 1 represent the discrete (qualitative) expression levels
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Definition 5 (State Graph) If lv is the level of an entity v in a state s ∈ §, the state graph 
of a BRN with transition relation T ⊆ §× § is a directed graph such that s→ s′ ∈ T  iff:
  • there is a unique v ∈ X such that slv �= s′lv and s
′
lv
= slv  Kv,Rlv;
  • and slu = s′lu∀u ∈ X \ v.
A state graph differs from its successor state by one component only, so if a state s has 
n elements to be evolved then it will have at most n successor states.
The discrete modeling formalism can be easily understood by a toy example. Consider 
the BRN shown in Fig. 3 consisting of two genes x and y (represented by x and y nodes), 
where y acts as an activator of x while y favors its own production (self-stimulation) and 
is inhibited by x. Even for arbitrary BRNs, such as this one, different sets of logical param-
eters can be inferred, leading to difficulties in selection of the parameters. A methodol-
ogy pioneered by Bernot et al. (2004), utilises the application of model checking over the 
state graphs generated by the possible sets of logical parameters. Model checking is an 
exhaustive exploratory approach applicable to graphs to check them for certain proper-
ties expressed under Computation Tree Logic (CTL) (Clarke et al. 1999). The details of 
the syntax and applicability of CTL, along with the explanation of the tool SMBioNet are 
given in detail by Khalis et al. (2009). The SMBioNet tool was applied on this BRN, using 
the CTL formula: (y = 2)→ AXAF(y = 2), (where A enforces execution of the given 
CTL in all paths and F imposes execution of the given CTL in at least one path Aslam 
et al. 2014) which states that once the protein y has achieved the level 2, it will remain at 
that level and induce mucus production. The application of this CTL generated a param-
eter set, given in state table (Table 1), which also shows the transitioning of states from a 
given state. Its state graph is also shown in Fig. 4, representing the behavior of the BRN by 
one cycle (0, 0)→ (0, 1)→ (1, 1)→ (1, 0) and stable steady state (1, 2).
Table 1 The state table of genes x and y
Rx, Ry represent resources of x and y respectively. Values 0, 1 and 2 in x and y columns show the expression levels of the 
respective genes. {} represents the absence of all activator and the presence of all inhibitors of an entity
x y Rx Ry Kx,Rx Ky,Ry
0 0 {} {x} 0 1
0 1 {x} {y} 1 1
0 2 {y} {x,y} 1 2
1 1 {y} {} 1 0
1 0 {} {} 0 0





Fig. 3 A toy BRN consisting of genes x and y where y activates x (shown by positive sign) and x inhibits y 
(shown by negative sign). Self-loop of y shows that y is self-activating
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Hybrid modeling
In hybrid modeling, both discrete and continuous features are combined to study diverse 
biological properties in detail (Ahmad et  al. 2009). In this modeling formalism, a sig-
moid-curve is discretized into piece-wise linear curve (Ahmad et al. 2007) as illustrated 
in Fig.  5. The delays governing the gene evolution are characterized as time intervals, 
which are measured using real-valued clocks (Ahmad et al. 2009).
In a BRN each gene is associated a clock to record evolution time of its expression. 
The clock is reset to zero after each transition whenever the expression passes from one 
level to another (Ahmad et al. 2009). In the current BRN, delays are taken as unvalued 
parameters to introduce the concept of Parametric Bio Linear hybrid Automaton (Bio-
LHA) (Ahmad et al. 2007, 2009, 2012; Ahmad and Roux 2008) that could be analyzed for 
certain delay constraints describing the stay conditions for the behaviours of BRN.
We denote by V and P, the sets of real valued variables and parameters, respectively. 
Let C = (V ,P), C ≤ (V ,P)) and C ≥ (V ,P)) represent the set of atomic constraints 
using only =, ≤ and ≥, respectively.
Definition 6 (Parametric Bio-Linear Hybrid Automaton) A Bio-Linear Hybrid Autom-
aton is a 6-tuple H =
〈







Fig. 4 The state graph of x and y genes; representing cyclic (homeostatic) and stable state (deadlock) behav-
iors of the system. The system evolves from silenced state (x,y) (0,0) leading towards (0,1) as in the absence of 
the inhibitor x, y is activated. Once the threshold value of 2 of y in the state (0, 2) is achieved (constant activa-
tion of y), it takes the system towards deadlock state (1, 2)






hv       0
Fig. 5 Evolution of clock variable hv. Here, dhv/dt = 1 represents the rate of evolution of clock hv associated 
with gene v, which evolves from low level to higher level 1 Ahmad et al. (2008). When a delay is measured 
then the respective clock is reset (hv ← 0)
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  • L is a finite set of locations;
  • l0 is the initial location;
  • P is the finite set of parameters (delays);
  • V is a finite set of real-valued variables (clocks);
  • E ⊆ L× C = (V ,P)× 2v × L is a finite set of edges. e = {l, g ,R, l′} ∈ E is the edge 
between the locations l and l′ with the guard g and the reset set R ⊆ V  contains the 
set of clocks which appears in g.
  • Inv assigns invariant condition as a conjunction of atomic constraints 
C ≤ (V ,P)) and C ≥ (V ,P)) to each location l ∈ L;
  • Diff L× V → {−1, 0, 1} assigns an evolution rate to each continuous variable v ∈ V  
(clocks) in each location l ∈ L.
The semantics of a parametric Bio-LHA is a timed transition system. It is defined 
according to the time domain T. We let T* = T  \{0}.
Definition 7 (Semantics of Bio-Linear Hybrid Automaton) Let ν be a valuation for the 
delay parameters P. The (T , ν)-semantics of a parametric Bio-LHA
is defined as a timed transition system SH = {S, si,T →} where: (1) 
S = {(l, ν)}|l ∈ L and ν |= Inv(L); (2) si = (l0, v0) represents initial state (a configura-
tion of initial location and initial values of real valued variables clocks); (3) the relation 
→⊆ S × T × S is defined for t ∈ T  as:
  • Discrete transitions: (l, v) → (l′, v′) iff ∃ {l, g ,R, l′} ∈ E such that g(v) = true, 
v′(h) = 0 if h ∈ R and v′(h) = v(h) if h /∈ R.
  • Continuous transitions: For t ∈ T*, (l, v) → (l′, v′) iff l′ = l, v′(h) = v(h)+
Diff (l, h)× t, and for every t ′ ∈ [0, t], (v(h)+ Diff (l, h)× t ′ |= Inv(l).
Definition 8 (Temporal Zone) A zone in which the discrete level of entities remains 
the same, however the clocks of the entities keep ticking until the evolution (activation 
or inhibition) of an entity takes place (Ahmad et al. 2008, 2009).
Definition 9 (Temporal State Space) The temporal state of a BRN comprises of the 
complete set of temporal zones derived from the discrete model of the respective BRN.
In the hybrid model of a BRN, we denote φ(t) for t ∈ R≥0, while the sequence of points 
of a trajectory and the set of all points in its state pace is denoted by S (Ahmad et al. 
2009). A particular trajectory is said to be viable, iff it remains within a prescribed region 
known as its viability domain (Ahmad and Roux 2008).
Definition 10 (Invariance kernel) An invariance kernel K ∈ S is the largest invariant 
subset of S iff for any point p ∈ K , any trajectory starting in p is viable in K.
H =
〈
L, lo, v,P, e, Inv,Diff
〉
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For the analysis of invariance kernel, the notion of Period (denoted by π) (Ahmad et al. 
2009) is introduced.
Definition 11 (Period) It is defined as sum of all the delays that a gene goes through 
sequentially and successively, once through each of all its expression levels in a cycle 
(Ahmad et al. 2009). It is denoted as π.
HyTech (Henzinger et al. 1997) is used to analyze the invariance kernel and conver-
gence domain, the results of which are expressed as linear constraints that specify the 
conditions under which a particular behaviour exists. (Ahmad et al. 2007, 2009; Ahmad 
and Roux 2008).
Discrete and hybrid modeling of the NF‑κB associated BRN
The regulatory pathway in Fig. 1 is represented by a labeled directed graph as shown in 
Fig. 6. Qualitative model of the BRN is derived by applying discrete formalism. For this 
purpose only qualitative data of the network is required, i.e., sign of interactions (+ or −), 
threshold order and weights for each interaction. For situations where the thresholds are 
weakly estimated, the logical approach could be an alternative (Thieffry and Thomas 1998).
In the feedback circuit (see Fig. 6) only the main regulators (HIV-1, TNF-α and NF-κ
B) are included and the logical formalism has been applied to observe the behaviors 
like multistationarity and homeostasis (Gouze 2009). The set of parameters is defined 
in Table  2, derived after performing several experiments (refer to Bibi et  al. 2011 for 
detailed BRN understanding).
GENOTECH tool (Ahmad 2009) is used to observe the dynamical behavior of the 
BRN through the generation of steady states. This tool facilitates the discrete modeling 
of a BRN. Apart from the discrete modeling, it also aids in analysis of steady state behav-
iors (cyclic and dead lock states). A hybrid model is also obtained by GENOTECH that 
integrates clocks to compute production and degradation delays for each entity in the 
BRN. HyTech tool is then applied to analyze this hybrid model which generates para-
metric constraints or stay conditions to explain the existence of a particular state (or 
behavior) (Fromentin et al. 2010). The work flow is sequentially illustrated in (Fig. 7).
Results
Parameter synthesis and Qualitative Model of NF‑κB associated BRN
The NF-κB associated BRN (illustrated in Fig. 6) was first modelled in SMBioNet as an 
input to generate the preferred logical parameter set. Trivial parameters of each entity, 
the resource sets of which contained only activators or inhibitors, were restricted to ‘nv’ 
and ‘0’ respectively. The CTL formulas used were:
(HIV = 0 ∧ TNFA = 0 ∧ NFkB = 0) →
EF(AG(HIV = 1,∧TNFA = 1 ∧ NFkB = 2)) ∧
(HIV = 0 ∧ TNFA = 0 ∧ NFkB = 0) →
EX(EF(HIV = 0 ∧ TNFA = 0 ∧ NFkB = 0)) ∧
(HIV = 0 ∧ TNFA = 1 ∧ NFkB = 2) →
AF(AG(HIV = 1 ∧ TNFA = 1 ∧ NFkB = 2))













Fig. 6 BRN of NF-κB responsible for the cytokine production and regulation. HIV stimulates NF- κB and 
TNF-α production while TNF-α in turn regulates HIV and NF-κB that helps HIV to replicate itself. Threshold of 2 
represents that HIV wins the battle to trans-activate itself even at low expression level of NF-κB immediately 
after entering into cellular environment while TNF-α will build at later points depending upon increased or 
greater levels of NF-κB
Table 2 State transition table: transition from  one state to  the next  state is given, here 
activators act as  resources while  absence of  an inhibitor is also taken as  its resource 
that  decides its K Parameter (e.g. absence of  TNF-α in  Ist row act as  a resource for  HIV 
that set K Parameter for HIV as 1)
States Resources K Parameters Transition to states
HIV TNF‑α NF‑κB RHIV RTNF-α RNF-κB KHIV KTNF-α KNF-κB
0 0 0 {TNF-α} {} {} 1 0 0 (1,0,0)
0 0 1 {TNF-α,NF-κB} {} {} 1 0 0 (1,0,1), (0,0,0)
0 0 2 {TNF-α,NF-κB} {NF-κB} {} 1 1 0 (1,0,2), (0,1,2), (0,0,1)
0 1 0 {} {} {TNF-α} 0 0 2 (0,0,0), (0,1,1)
0 1 1 {NF-κB} {} {TNF-α} 1 0 2 (1,1,1), (0,0,1), (0,1,2)
0 1 2 {NF-κB} {NF-κB} {TNF-α} 1 1 2 (1,1,2)
1 0 0 {TNF-α} {HIV} {HIV} 1 1 2 (1,1,0), (1,0,1)
1 0 1 {TNF-α,NF-κB} {HIV} {HIV} 1 1 2 (1,1,1), (1,0,2)
1 0 2 {TNF-α,NF-κB} {HIV, NF-κB} HIV 1 1 2 (1,1,2)
1 1 0 {} {HIV} {HIV,TNF-α} 0 1 2 (0,1,0), (1,1,1)
1 1 1 {NF-κB} {HIV} {HIV,TNF-α} 1 1 2 (1,1,2)
1 1 2 {NF-κB} {HIV, NF-κB} {HIV,TNF-α} 1 1 2 ( )
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The first formula states that from an arbitrary initial state where all three entities have 
the level ‘0’, there should exist a trajectory where the system enters a deadlock state in 
which the HIV proteins are at level ‘1’, TNF-α is at level ‘1’, and NF-κB is at level ‘2’. Like-
wise, the second formula starts from the same arbitrary initial state and enforces that 
there should exist at least one trajectory from which this initial state is again reached, 
meaning that there should exist at least one cycle from this state. The third and final for-
mula states that once TNF-α and NF-κB are at their respective nv in the absence of HIV, 
then the system will always end up in the diseased steady state. These formulas gener-
ated 3 parameter sets, which differed only at the parameter KNF−κB{HIV }. As the trend 
in all the parameter sets was that of NF-κB being induced in the presence of HIV, we 
selected the parameter set which allowed NF-κB to achieve its maximum threshold level 
of ’2’ on this logical parameter assuming that full activation (optimal expression) of NF-κ
B is lethal for infected macrophages to fight against HIV. The selected parameter set ena-
bles all the entities to interact with each other corresponding to naturally occurring phe-
nomenon while maintaining interdependencies of participating entities upon each other 
(for stimulation or suppression). In addition, the logical parameters are given in Table 2.
State graph
Based on the selected logical parameters, a state graph is generated as shown in Fig. 8. 
There are two types of states in the graph, the states with certain incoming and outgoing 
arrows known as steady states while there is a state (1,1,2) with only incoming arrows 
(no outgoing arrow) it represents stable steady state (in red). A close analysis of the state 
graph reveals two cycles exiting within it (in green) that represent a probable mecha-
nism of homoeostasis once the system encounters an HIV infection representing that 
how the BRN behaves after viral entry and recovery control mechanism to fight against 










Fig. 7 Work flow. Step-wise representation of methodology applied to construct BRN and subsequent state 
graph analysis using Graphviz tool. HyTECH model is finally developed to incorporate time-delays for the 
activation and inhibition of each entity
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when virus stimulates the immune system to produce antibodies against HIV-1. The sta-
ble steady state represents a diseased state (the onset of AIDs) where all the proteins 
are over expressed. A total of 6 paths lead towards stable steady state (1,1,2) from the 
initial state (1,0,0), which indicates HIV infection. All these paths enter the homeostatic 
cycle via the state (1,1,0) and divert towards stable steady state in case of violation of the 
condition required to be in the cycle (discussed in the “Hybrid modeling results” sec-
tion). The complete model of the system given in Fig. 8 shows cyclic states along with 
the steady state where the cyclic states are associated with green arrows while red arrows 
lead towards stable steady state.
Real‑time hybrid model
The qualitative modeling process generated all possible discrete states (Fig. 8) and their 
transitions which give further insights into the steady states behaviors. These steady 
states (cycles and stable states) are in agreement with the general hypothesis of wet-
lab and clinical experiments. After applying the discrete modeling formalism on NF-κB 
associated BRN, its hybrid model is obtained for the BRN with help of parametric con-
straints. Hybrid modeling allowed us to compute the necessary and sufficient conditions 
for the existence of different behaviors.
The BRN under study generated two cycles in HyTech, having some overlapping cyclic 
states. The presence of inequality or equality in the resulting constraints determines the 
stability or instability of the cycle respectfully. Of the two cycles, only one was able to 
converge to its invariance kernel, and is thus the only one analysed (see Table 3 for the 
cycle and delay constraints).
Fig. 8 State graph of the BRN shows a complete set of states. Each state represents the discrete expression 
levels of the entities in the order of HIV, TNF-α, NF-κB. Green arrowsrepresent cyclic trajectories maintaining 
the recovery mechanism. Whereas, the paths leading into stable steady state (1,1,2) are represented by red 
dashed arrows
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By varying time delays, i.e., the delay required by an entity to evolve or degrade, sys-
tem dynamics can be accurately observed. This new model is then analyzed with linear 
hybrid model checker tool HyTech (Henzinger et al. 1997) in order to extract the con-
straints for cyclic states, the significant ones of which are discussed below:
Constraint 1: δ+NFKB010 + |δ−NFKB001| + 2|δ−TNF−A011| = δ+HIV 000 + |δ−HIV 110| This equality 
constraint revealed the following relation between HIV and NF-κB.
where δ+NFKB010 represents production delay of NF-κB in the logical state 010 while 
δ
−
NFKB001 represents degradation delay of NF-κB in the logical state 001 and π represents 
time period (sum of positive and negative time delays).
These relations capture the general trend of HIV infection and immune stimulation 
where the period of HIV infection is greater than the period of NF-κB, this is graphically 
represented in Fig.  9b. This constraint shows slow propagation of viral infection that 
strengthens the immune system and hence lowers the risks of viral attack for surround-
ing cells (Bosque 2009). It is important to note that the real trend of a gene expression 
may require more time (as it may go through lazy stages where no increase or decrease 
occurs) to complete a period (Ahmad et al. 2009).
Constraint 2: δ+TNF−A100+|δ−TNF−A011| ≤ δ+HIV 000+|δ−HIV 110| The relation between HIV and 
TNF-α is also extracted as follows.
This constraint is explained by the fact that cytokine production is boosted exponen-
tially early in immune attack to combat viral attack by HIV-1. Here the delay associated 
(2)π(HIV ) ≥ π(NF-κB)
(3)π(HIV ) ≥ π(TNF-α)
Table 3 Constraints for the invariant cycle
The conjunction of constraints 1–13 characterize the invariance kernel. The violation of these constraints could take system 
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with TNF-α for its expression and degradation (δ+ production delay at state 100 and δ− 
degradation delay at state 011) is less than the complete period of HIV at states 000 and 
011. Thus, the qualitative period of TNF-α is traversed faster the period of HIV, in an 
attampt to hamper HIV proteins entry into surrounding macrophages. It is evidenced by 
severe inflammation to control initial burst of viral proliferation (represented in Fig. 9a). 
It showed that after the release of HIV proteins into the cellular machinery, production 
of cytokines occurs rapidly as compared to viral replication, i.e., the period of HIV ends 
after the period of TNF-α. It leads to the condition where TNF-α reaches its destination 
earlier as compared to HIV in order to activate or enhance the immune system.
Constraint 3: δ+HIV 000 + |δ−HIV 110| ≤ δ+NF−KB110 + |δ−NF−KB001|+ 2|δ−TNF−A011| After getting 
infected with HIV, some patients remain healthy for some years thats shows clinical latency 
period. However, the virus somehow manages to progress despite the active immune sys-
tem. This condition is a clear depiction of such a scenario where HIV’s qualitative period 
progresses ahead of NF-κB and TNF-α causing failure of immune system. This constraint 
is an important candidate to represent critical points in later stages of HIV infection hav-
ing inefficient T cells response leading to immune escape of HIV. It illustrates the situation 
when HIV gets into the immune system and starts proliferating its number via the tran-
scription factor NF-κB, immune system takes more time delay to produce inflammatory 
cytokines (TNF-α) as compared to the viral propagation (production) (Fig. 10). This time 
delay is generally followed after the period of clinical latency has passed.
Discussion
In this study, qualitative and hybrid models of the BRN for immune activation (upon 



















Fig. 9 Dummy/graphical representation of HIV time period relative to TNF-α a and NF-κB b
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to estimate the important dynamic properties characterized by regulation delays. On the 
basis of HyTech results, two important relations are drawn from the set of constraints: 
π(HIV ) ≥ π(NF-κB) and π(HIV ) ≥ π(TNF-α).
In order to maintain the homeostatic balance of human immune defense, the invasion 
period of HIV must span longer duration as compared to TNF-α and NF-κB during the 
initial phases of viral attack. This will tend to reduce the viral proteins ability to start 
its replication rapidly, giving strength to body’s innate immunity to fight against HIV-1 
pathogenesis. It reflects an important relationship between HIV, TNF-α and NF-κB. 
When the progression of HIV proteins is slow in comparison to immune defense mecha-
nism, the virus normally takes much longer to infect and override the whole immune 
system of the infected individual. This phenomenon is followed by rapid generation of 
cytokines by cellular transcriptional machinery NF-κB while there is a considerably slow 
replication and invasion of HIV in the body. It shows frequent evolution of NF-κB and 
TNF-α and relatively stable behavior of HIV in comparison to the other two. However, if 
the fore mentioned constraint is violated, the system would get stuck in the stable steady 
state (1,1,2) shown in Fig.  8, where the chances of survival diminishes. This situation 
is generally seen during the period of acute infection. Keeping this in view, longer sur-
vival time of patients (clinical latency periods) are observed in case of longer qualitative 
period of HIV than that of immune defense elements (i.e., NF-κB and TNF-α). Further-
more, at initial stages of HIV infection, high-levels of CD8+ T cell frequencies have been 
observed to correlate with the control of viral replication (Wilson et al. 2000; Allen et al. 
2000; Davenport et al. 2004). From this, it can be concluded that while designing drugs 
against HIV-1, the delay time for HIV-1 proteins’ expression must be kept greater than 
those of NF-κB and TNF-α by administrating greater dose of cytokines (TNF-α).
When the time period for HIV’s protein expression is lesser, it indicates that the sys-
tem is attainting the stage of viral setpoint. At this stage, number of TNF-α decreases 
in T lymphocytes and this can be seen by the shifting of the initial steady state of TNF-
α (cytokines) to a new equilibrium value. This new equilibrium value is lower than the 
preinfection value (Fauci 1996). At this stage, an exponential increase in virus load may 
be observed, reaching a peak and finally declining to the steady state level also called 
as viral setpoint (Kaufmann et al. 1998; Lindbäck et al. 2000). HIV setpoint serves as a 










Fig. 10 Dummy/graphical representation of period of TNF-α relative to HIV
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In vitro studies have shown that HIV-infected CD4+ T cells are lysed by HIV viral 
proteins and by mathematical modeling the primary HIV infection kinetics, it has been 
revealed that the viral-induced cytopathicity and susceptible T cells (also called the ’tar-
get-cell limited model’) controls the infection (Somasundaran and Robinson 1987; Mul-
ler and Bonhoeffer 2003).
By observing the different behavioral patterns of HIV, TNF-α and NF-κB with respect 
to time, it can be observed that it depends upon time delays taken by these key play-
ers to incite or repress a specific response. These conditions help us to understand that 
how the equilibrium is maintained in the body upon arrival of any invader (or infec-
tion), e.g., if the qualitative period of HIV remains slower than TNF-α, no symptoms will 
appear until this condition is violated. In this way the immune cells (macrophages) can 
suppress the viral infected cells or hinder their binding to macrophages by speeding up 
the production of cytokines, chemokines and several other growth factors essential for 
immune stimulation. This model of HIV-1 infection can be further extended to explore 
disease behaviour to get deeper insights. The involvement of Rel Homology domain with 
discriminatory domains (Rel A and Rel B) having contrasting functions make NF-κB 
a very interesting candidate for drug designing. The contrasting role of Rel B in anti-
inflammation as compared to Rel A (causing inflammation) revealed interesting results 
in initial clinical findings. Experimental data shows that suppression of Rel A domain by 
introducing Rel B externally (or making it active by other means) tends to slow down the 
disease progression in the body and helps to inhibit inflammation caused by Rel A.
By adding more entities in the BRN understudy, exact therapeutic targets can be found 
by docking and simulation studies of the interacting proteins. These findings would aid 
in the process of drug designing. Model checking techniques could help us to design a 
computer aided tool for rapid immunological analysis. Real time modeling and its appli-
cations would pave the way towards predicting the preventive medicines, which will give 
the advancement in medicine developed for the treatment of AIDS.
Conclusion
Qualitative and hybrid models of the Biological Regulatory Network (BRN) of immune 
response against HIV-1 infection were constructed to explore the qualitative and real-
time properties of the dynamics of the three entities HIV, (NF-κB) and TNF-α. The 
qualitative model predicted one stable state showing the over expression of all the inter-
acting entities and two cycles representing a recovery mechanism of the BRN from HIV 
infection. The hybrid model was further analyzed to predict the delay constraints for the 
existence of the invariant cycle. Two important delay constraints were identified which 
show the oscillatory periods of HIV is greater than the oscillatory periods of (NF-κB) 
and TNF-α. These findings may help in the design of new generation drugs in the treat-
ment of AIDS.
Authors’ contributions
Conceived and designed the experiments:ZB JA. Performed the experiments: ZB. Analyzed the data: ZB JA AS SHKT. 
Contributed reagents/materials/analysis tools: ZB JA AS SHKT JA AA SS SK. Wrote the paper: ZB JA. All authors read and 
approved the final manuscript.
Author details
1 Research Center for Modeling and Simulation (RCMS), National University of Sciences and Technology (NUST), 
H13, Islamabad 44000, Pakistan. 2 Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Sci-
ences and Technology (NUST), H13, Islamabad 44000, Pakistan. 3 Department of Bioinformatics and Biotechnology, 
Page 17 of 18Bibi et al. Complex Adapt Syst Model  (2016) 4:1 
International Islamic University, H12, Islamabad 44000, Pakistan. 4 Department of Computer Science, University of Pesha-
war, Peshawar 25120, Pakistan. 
Acknowledgments
This research work was supported by Higher Education Commission (HEC) of Pakistan, National University of Sciences 
and Technology (NUST) and International Islamic University, Islamabad, Pakistan.
Competing interests
The authors declare that they have no competing interests.
Received: 6 November 2015   Accepted: 22 December 2015
References
Douek DC, Brenchley JM, Ambrozak DR, Betts MR, Hill BJ, Okamoto Y, Casazza JP, Kuruppu J, Kunstman K, Wolinsky S, 
Grossman Z, Dybul M, Oxenius A, Price DA, Connors M, Koup RA (2002) HIV preferentially infects hiv-specific CD4+ t 
cells. Nature 417(6884):95–98
Legler DF, Micheau O, Doucey M-A, Tschopp J, Bron C (2003) Recruitment of tnf receptor 1 to lipid rafts is essential for 
tnfα-mediated nf-κb activation. Immunity 18(5):655–664
Vitale RFF, Ribeiro FDAQDEA (2007) The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in 
middle ear cholesteatoma. Braz J Otorhinolaryngol 73(1):117–121
Bingham CO 3rd (2002) The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and 
inflammation. J Rheumatol 65:3–9
Herbein G, Montaner LJ, Gordon S (1996) Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus 
type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J Virol 70(11):7388–7397
Lane BR, Markovitz DM, Woodford NL, Rochford R, Strieter RM, Coffey MJ (1999) Tnf-alpha inhibits hiv-1 replication in 
peripheral blood monocytes and alveolar macrophages by inducing the production of rantes and decreasing c-c 
chemokine receptor 5 (ccr5) expression. J Immunol 163(7):3653–3661
Swami M (2013) HIV infections: Restricting HIV from macrophages. Nat Med 19(4):416. doi:10.1038/nm.3166
Herbein G, Gras G, Khan K, Abbas W (2010) Macrophage signaling in HIV-1 infection. Retrovirology 7(1):34. 
doi:10.1186/1742-4690-7-34
Melikyan GB (2008) Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovi-
rology 5(1):111
Herbein G, Keshav S, OLLIN M, Montaner L, Gordon S (1994) HIV-1 induces tumour necrosis factor and IL-1 gene expres-
sion in primary human macrophages independent of productive infection. Clin Exp Immunol 95(3):442–449
Ghosh S, Karin M (2002) Missing pieces in the nf-κb puzzle. Cell 109(2):81–96
Grey ST (2008) Regulating inflammation: The ying and yang of nf-κb activation. Immunol Cell Biol 86(4):299–300
Brandman O, Meyer T (2008) Feedback loops shape cellular signals in space and time. Science 322(5900):390–395
Thomas R, Thieffry D (1995) Dynamical behaviour of biological regulatory networks. I. Biological role of feedback loops 
and practical use of the concept of the loop-characteristic state. Bull Math Biol 57:247–276
Thomas R et al (1998) Laws for the dynamics of regulatory networks. Int J Dev Biol 42:479–485
Gagneur J, Casari G (2005) From molecular networks to qualitative cell behavior. FEBS Lett 579(8):1867–1871
De Jong H, Gouzé J-L, Hernandez C, Page M, Sari T, Geiselmann J (2004) Qualitative simulation of genetic regulatory 
networks using piecewise-linear models. Bull Math Biol 66(2):301–340
Bibi Z, Ahmad J, Niazi U (2011) Dynamical modeling of the biological regulatory network of nf-kb activation in hiv-1. In: 
Computer Networks and Information Technology (ICCNIT), 2011 International Conference On, pp. 47—51. IEEE
Ahmad J, Bernot G, Comet J-P, Lime D, Roux O (2007) Hybrid modelling and dynamical analysis of gene regulatory net-
works with delays. ComPlexUs 3(4):231–251
Fromentin J, Eveillard D, Roux O (2010) Hybrid modeling of biological networks: mixing temporal and qualitative biologi-
cal properties. BMC Syst Biol 4(1):79
Ahmad J, Niazi U, Mansoor S, Siddique U, Bibby J (2012) Formal modeling and analysis of the mal-associated biological 
regulatory network: insight into cerebral malaria. PLoS One 7(3):33532
Ahmad J, Bourdon J, Eveillard D, Fromentin J, Roux O, Sinoquet C (2009) Temporal constraints of a gene regulatory net-
work: refining a qualitative simulation. Biosystems 98(3):149–159. doi:10.1016/j.biosystems.2009.05.002. (Evolving 
gene regulatory networks)
Ahmad J, Roux O (2008) Invariance kernel of biological regulatory networks. In: Proceedings of the 2008 IEEE Interna-
tional Conference on Bioinformatics and Biomedicine. BIBM ’08, pp. 135–140. IEEE Computer Society, Washington, 
DC. doi:10.1109/BIBM.2008.64. http://dx.doi.org/10.1109/BIBM.2008.64
Thieffry, D, Thomas R (1998) Qualitative analysis of gene networks. Pacific Symposium on Biocomputing. pp 77–88
Thomas R, D’Ari R (1990) Biological feedback. Taylor & Francis, London. http://books.google.com.pk/
books?id=WrRVk7B\_NLgC
Bernot G, Comet J-PP, Richard A, Guespin J (2004) Application of formal methods to biological regulatory networks: 
extending thomas’ asynchronous logical approach with temporal logic. J Theor Biol 229(3):339–347. doi:10.1016/j.
jtbi.2004.04.003
Clarke EM Jr, Grumberg O, Peled DA (1999) Model Checking. MIT Press, Cambridge
Khalis Z, Comet J-P, Richard A, Bernot G (2009) The SMBioNet method for discovering models of gene regulatory net-
works. Genes, genomes and genomics 3(1):15–22
Page 18 of 18Bibi et al. Complex Adapt Syst Model  (2016) 4:1 
Aslam B, Ahmad J, Ali A, Parachaa RZ, Tareen SHK, Niazi U, Saeed T (2014) On the modelling and analysis of the 
regulatory network of dengue virus pathogenesis and clearance. Comput Biol Chem 53:277–291. doi:10.1016/j.
compbiolchem.2014.10.003
Ahmad J, Roux O, Bernot G, Comet J-P (2008) Analysing formal models of genetic regulatory networks with delays. Int J 
Bioinform Res Appl 4(3):240–262
Henzinger TA, Ho P-H, Wong-toi H (1997) Hytech: A model checker for hybrid systems. Softw Tools Technol Transfer 
1:460–463
Gouze JL (1998) Positive and negative circuits in dynamical systems. J Biol Syst 6(01):11–15
Ahmad J (2009) Modélisation hybride et analyse des dynamiques des réseaux de régulations biologiques en tenant 
compte des délais
Bosque A, Planelles V (2009) Induction of HIV-1 latency and reactivation in primary memory CD4+ t cells. Blood 
113(1):58–65
Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK (2000) Epitopes involved in antibody-mediated 
protection from ebola virus. Science 287(5458):1664–6
Allen TM, O’Connor DH, Jing P, Dzuris JL, Mothé BR, Vogel TU, Dunphy E, Liebl ME, Emerson C, Wilson N et al (2000) 
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 
407(6802):386–390
Davenport MP, Ribeiro RM, Perelson AS (2004) Kinetics of virus-specific CD8+ t cells and the control of human immuno-
deficiency virus infection. J Virol 78(18):10096–10103
Fauci AS (1996) Host factors and the pathogenesis of HIV-induced disease. Nature 384(6609):529–534
Kaufmann GR, Cunningham P, Kelleher AD, Zaunders J, Carr A, Vizzard J, Law M, Cooper DA et al (1998) Patterns of viral 
dynamics during primary human immunodeficiency virus type 1 infection. J Infect Dis 178(6):1812–1815
Lindbäck S, Karlsson AC, Mittler J, Blaxhult A, Carlsson M, Briheim G, Sönnerborg A, Gaines H, Group, K.I.P.H.I.S et al (2000) 
Viral dynamics in primary HIV-1 infection. Aids 14(15):2283–2291
Burg D, Rong L, Neumann AU, Dahari H (2009) Mathematical modeling of viral kinetics under immune control during 
primary HIV-1 infection. J Theor Biol 259(4):751–759
Somasundaran M, Robinson H (1987) A major mechanism of human immunodeficiency virus-induced cell killing does 
not involve cell fusion. J Virol 61(10):3114–3119
Muller V, Bonhoeffer S (2003) Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infec-
tion. Curr Drug Targets Infect Disord 3(4):329–344
